Procurement Summary
Country: USA
Summary: Dow Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award
Deadline: 30 Sep 2026
Posting Date: 05 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 140656182
Document Ref. No.: HT942526ALSRPTIA
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
CPV Classification
73110000 - Research services
33651510 - Antisera
33192150 - Therapy beds
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Summary: The Fiscal Year 2026 (Fy26) Amyotrophic Lateral Sclerosis Research Program (Alsrp) Therapeutic Idea Award (Tia) Supports New, Innovative, High-Risk, High-Gain Ideas Aimed At Amyotrophic Lateral Sclerosis (Als) Drug Or Therapy Discovery. The Studies Supported By This Award Mechanism Are Expected To Be Hypothesis-Driven And Generate Preliminary Data For Future Avenues Of Therapeutic Investigation.Distinctive Features: Potential Impact And Innovation Are Important Features Of The Tia. Applications May Demonstrate The Ability To Achieve Interpretable Results In The Absence Of Preliminary Data Supporting The Hypothesis. While The Inclusion Of Preliminary Data Is Not Prohibited, The Strength Of The Application Should Rely On The Approach.Eligibilityeligible Applicantsmiscellaneousunrestrictedadditional Informationgrantor Contact Informationdescriptionebrap Help Desk Phone: 301-682-5507 Email: [email protected] Help Deskdocumentsfile Namedescriptionlast Updatedfy26 Alsrp Tia Program Announcementmay 4, 2026 01:51 Pm Utclink To Additional Information--Closing: September 30, 2026
Posted Date: 2026-05-04 00:00:00
Funding instrument type: Grant
Documents
Tender Notice